rs556999563

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_058246.4(DNAJB6):​c.706G>A​(p.Asp236Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,528,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D236G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00044 ( 0 hom. )

Consequence

DNAJB6
NM_058246.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.641

Publications

2 publications found
Variant links:
Genes affected
DNAJB6 (HGNC:14888): (DnaJ heat shock protein family (Hsp40) member B6) This gene encodes a member of the DNAJ protein family. DNAJ family members are characterized by a highly conserved amino acid stretch called the 'J-domain' and function as one of the two major classes of molecular chaperones involved in a wide range of cellular events, such as protein folding and oligomeric protein complex assembly. This family member may also play a role in polyglutamine aggregation in specific neurons. Alternative splicing of this gene results in multiple transcript variants; however, not all variants have been fully described. [provided by RefSeq, Jul 2008]
DNAJB6 Gene-Disease associations (from GenCC):
  • muscular dystrophy, limb-girdle, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6)
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01799947).
BP6
Variant 7-157409809-G-A is Benign according to our data. Variant chr7-157409809-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 288876.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000184 (28/152306) while in subpopulation SAS AF = 0.000621 (3/4830). AF 95% confidence interval is 0.000194. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 28 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAJB6NM_058246.4 linkc.706G>A p.Asp236Asn missense_variant Exon 9 of 10 ENST00000262177.9 NP_490647.1 O75190-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAJB6ENST00000262177.9 linkc.706G>A p.Asp236Asn missense_variant Exon 9 of 10 1 NM_058246.4 ENSP00000262177.4 O75190-1

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152188
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000286
AC:
37
AN:
129282
AF XY:
0.000411
show subpopulations
Gnomad AFR exome
AF:
0.000158
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000357
Gnomad OTH exome
AF:
0.000250
GnomAD4 exome
AF:
0.000436
AC:
600
AN:
1376136
Hom.:
0
Cov.:
31
AF XY:
0.000416
AC XY:
282
AN XY:
677818
show subpopulations
African (AFR)
AF:
0.0000642
AC:
2
AN:
31168
American (AMR)
AF:
0.00
AC:
0
AN:
35392
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24994
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35410
South Asian (SAS)
AF:
0.000635
AC:
50
AN:
78778
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35458
Middle Eastern (MID)
AF:
0.000247
AC:
1
AN:
4054
European-Non Finnish (NFE)
AF:
0.000490
AC:
526
AN:
1073602
Other (OTH)
AF:
0.000367
AC:
21
AN:
57280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
34
68
102
136
170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152306
Hom.:
0
Cov.:
34
AF XY:
0.000201
AC XY:
15
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41572
American (AMR)
AF:
0.000131
AC:
2
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000227
Hom.:
0
Bravo
AF:
0.000155
ExAC
AF:
0.000174
AC:
11

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jul 27, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 07, 2024
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) Benign:1
Dec 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T;T;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.79
T;T;T
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.018
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.33
N;.;.
PhyloP100
0.64
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
0.21
N;N;.
REVEL
Benign
0.032
Sift
Benign
0.32
T;T;.
Sift4G
Benign
0.42
T;T;T
Polyphen
0.0020
B;P;.
Vest4
0.14
MVP
0.42
MPC
0.34
ClinPred
0.033
T
GERP RS
1.6
Varity_R
0.017
gMVP
0.41
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs556999563; hg19: chr7-157202503; COSMIC: COSV51096550; API